Loading...

Shenzhen Neptunus Interlong Bio-technique Company Limited

8329.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$0.16
HK$-0.01(-3.01%)

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Company Profile & Overview

Explore Shenzhen Neptunus Interlong Bio-technique Company Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) Company Profile & Overview

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, researches, develops, produces, and sells medicines in the People's Republic of China. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology products. In addition, the company manufactures herbal medicines and generic drugs products, as well as medical devices. The company is based in Shenzhen, the People's Republic of China. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOFeng Zhang

Contact Information

https://www.interlong.com
8675526411869
Neptunus Yinhe Technology Mansion, Shenzhen, 518000

Company Facts

1,485 Employees
IPO DateSep 12, 2005
CountryCN
Actively Trading

Frequently Asked Questions

;